Skip to main navigation Skip to search Skip to main content

Novel 4-(2-pyrimidinylamino)benzamide derivatives as potent hedgehog signaling pathway inhibitors

  • Minhang Xin
  • , Liandi Zhang
  • , Chongxing Tu
  • , Feng Tang
  • , Jun Wen
  • Jiangsu Simcere Pharmaceutical Co. Ltd

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

A series of novel hedgehog signaling pathway inhibitors have been designed and synthesized based on our previously reported scaffold of 4-(2-pyrimidinylamino)benzamide. The Hh signaling pathway inhibitory activities were evaluated by Gli-luciferase reporter method and most compounds showed more potent inhibitory activities than vismodegib. Three compounds were picked out to evaluated in vivo for their PK properties, and compound 23b bearing a 2-pyridyl A-ring and (morpholin-4-yl)methylene at 3-position of D-ring demonstrated satisfactory PK properties. This study suggested the 4-(2-pyrimidinylamino)benzamides were a series of potent Hh signaling pathway inhibitors, deserving to further structural optimization.

Original languageEnglish
Pages (from-to)5029-5036
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume26
Issue number18
DOIs
StatePublished - 1 Oct 2018

Keywords

  • 4-(2-Pyrimidinylamino)benzamide
  • Hedgehog signaling pathway inhibitors
  • In vivo
  • SAR

Fingerprint

Dive into the research topics of 'Novel 4-(2-pyrimidinylamino)benzamide derivatives as potent hedgehog signaling pathway inhibitors'. Together they form a unique fingerprint.

Cite this